Hazard Warning Label Design and Compliance Certification

The contract requires the design, review, and certification of hazard warning labels for benzocaine gel to ensure full compliance with OSHA’s Hazard Communication Standard and DFARS regulations. This work must be completed prior to contract award and is intended to support the safe handling, storage, and transportation of the pharmaceutical product within federal supply chains. The effort involves developing accurate, legally compliant labeling that reflects the chemical hazards of benzocaine gel, including appropriate signal words, pictograms, hazard statements, and precautionary measures, all aligned with mandated federal safety frameworks. This subcontract is issued under NAICS code 541620, indicating professional, scientific, and technical services related to design and compliance, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as FPO with ZIP code 96667, indicating a military mail address likely associated with overseas or secure operations. Responses are due by May 18, 2026, with the solicitation posted on May 11, 2026, and all submissions must be made through the DIBBS platform. No set-aside provisions are specified, and the work is critical to maintaining regulatory adherence across DoD medical supply pathways.